Search Clinical Trials
By Condition
By Location (USA)
By Location (Other)
By Sponsor
Resources
Privacy Policy
About Us
Disclaimer
Treatment of neutropenic patients with fever who are suspected to have a gram positive infection (a specific kind of bacteria) Clinical Trials Information presented on Clinical Trials Search is not designed to be a substitute for proven healthcare advice, travels to or treatment by using a genuine medical doctor. We are not physicians. Always confer with your doctor on Treatment of neutropenic patients with fever who are suspected to have a gram positive infection (a specific kind of bacteria) conditions. Clinical Trials Search.org is a site devoted to listing clinical research studies in human subjects. Treatment of neutropenic patients with fever who are suspected to have a gram positive infection (a specific kind of bacteria) Clinical research trials and Treatment of neutropenic patients with fever who are suspected to have a gram positive infection (a specific kind of bacteria) healthcare trials take place in many of cities across the United States of America. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials generally evaluate the effectiveness of new drugs. The function of the studies / undertakings is to answer specific human medical questions. Clinical trials are a popular means for mDs, government agencies, and private sector companies to find treatments for all forms of conditions, including Treatment of neutropenic patients with fever who are suspected to have a gram positive infection (a specific kind of bacteria). Treatment of neutropenic patients with fever who are suspected to have a gram positive infection (a specific kind of bacteria) Clinical Trials and other clinical trials allow for volunteers to access medical treatment alternatives before they are available to the masses. Many times the test subjects undergo treatment for without cost, and occasionally they are compensated for their time. Occasionally there is a cost for a Treatment of neutropenic patients with fever who are suspected to have a gram positive infection (a specific kind of bacteria) clinical trial. Test subjects oftentimes recieve the best healthcare possible for their Treatment of neutropenic patients with fever who are suspected to have a gram positive infection (a specific kind of bacteria) condition. Hazards are a reality, nonetheless, and might include additional or frequent doctor trips, healthcare hazards (perhaps life-jeopardizing), and/or the treatment being ineffective. Trials are federally regulated with rigid guidelines to protect clinical trials subjects.

Home > "T" Clinical Trials Conditions > Treatment of neutropenic patients with fever who are suspected to have a gram positive infection (a specific kind of bacteria)

Treatment of neutropenic patients with fever who are suspected to have a gram positive infection (a specific kind of bacteria)



Treatment of neutropenic patients with fever who are suspected to have a gram positive infection (a specific kind of bacteria)

For Condition: Neutropenia,Fever,Neoplasms,Gram-Positive Bacterial Infections
Status: Completed
Sponsor(s): Pfizer ,
Synopsis: This study will treat patients who have fever and neutropenia (after cancer chemotherapy) that is possibly due to a specific bacteria (gram positive bacteria)
Details:
Eligibility:
Study Type:
  Interventional, Treatment
Minimum Age/Maximum Age: 13 Years/
Genders: Both
Protocol Entry Criteria: Other specific inclusion/exclusion criteria may apply. In order to determine eligibility, further examination by the investigator is necessary. Inclusion Criteria: - Patients must have neutropenia (ANC less than 500) with fever (oral temp 38.3 C). - Patients must have a cancer with recent chemotherapy and risks factors for gram positive infections. Exclusion Criteria: - Patients with fever due to known causes. - Patients with HIV. - Patients with recent bone marrow transplant. - Patients with an infected indwelling catheter that cannot be removed. - Patients who have received more than one day of another antibiotic before entering the trial. - Patients with endocarditis, osteomyelitis, meningitis, CNS infections.
Total Enrollment: 

Location and Contact Information:

Research Center
Tacoma,  Washington,  98405
United States
 

Research Center
Richmond,  Virginia,  23249
United States
 

Research Center
Lexington,  Kentucky,  40536
United States
 

Research Center
Los Angeles,  California,  90033
United States
 

Research Center
Bronx,  New York,  10467-2490
United States
 

Research Center
Kalamazoo,  Michigan,  49001
United States
 

Research Center
Maywood,  Illinois,  60153
United States
 

Research Center
Houston,  Texas,  77030-4211
United States
 

Research Center
Youngstown,  Ohio,  44501
United States
 

Research Center
Springfield,  Illinois,  62701
United States
 

Research Center
Richmond,  Virginia,  23294
United States
 

Research Center
Houston,  Texas,  77030
United States
 

Research Center
Falls Church,  Virginia,  22042
United States
 

Research Center
Worcester,  Massachusetts,  01655
United States
 

Research Center
Orange,  California,  92868
United States
 

Research Center
Jackson,  Tennessee,  38301
United States
 

Research Center
San Diego,  California,  92134
United States
 

Research Center
Perth Amboy,  New Jersey,  08861
United States
 

Research Center
Hato Rey,  ,  00985
Puerto Rico
 

Research Center
Milwaukee,  Wisconsin,  53226
United States
 

Research Center
Miami,  Florida,  33136
United States
 


Additional Information:
Study ID Numbers:
  M/1260/0079; 
Study Start Date: 
Record last reviewed: March 2004
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00035425

Other Neutropenia Studies:
1. Developmental Study on Fatigue in Cancer

2. A Phase I, Open Label, Dose Escalation Study of a New Formulation of Calcitriol (DN-101) for Safety, Tolerability, and Pharmacokinetics in Patients with Advanced Malignancies

3. Kanglaite Injection Phase I Study

4. Collection of Blood from Patients with Cancer

5. A Safety and Effectiveness Study of Aroplatin in Patients with Advanced Solid Malignancies

Related Studies:

Other Neutropenia Clinical Trials
Other Illinois Clinical Trials
Other Maywood Clinical Trials

Treatment of neutropenic patients with fever who are suspected to have a gram positive infection (a specific kind of bacteria)

Modify your Search

  Other Neutropenia Clinical Trials
  Other Illinois Clinical Trials
  Other Maywood Clinical Trials


Warning: include(/var/www/cgi-bin/traxis/counter.php) [function.include]: failed to open stream: No such file or directory in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103

Warning: include() [function.include]: Failed opening '/var/www/cgi-bin/traxis/counter.php' for inclusion (include_path='.:/usr/local/lib/php') in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103